Literature DB >> 14715242

Opposite effects of prostaglandin-J2 on VEGF in normoxia and hypoxia: role of HIF-1.

Alicja Józkowicz1, Anneliese Nigisch, Joanna Wegrzyn, Guenter Weigel, Ihor Huk, Józef Dulak.   

Abstract

The vascular endothelial growth factor (VEGF) is produced in response to hypoxia or inflammatory cytokines. In normoxia VEGF synthesis is upregulated by 15-deoxy-Delta(12,14)-prostaglandin-J(2) (15d-PGJ(2)) via induction of heme oxygenase-1 (HO-1). Here we compared the influence of 15d-PGJ(2) on VEGF expression in human microvascular endothelial cells in normoxia (approximately 20% O(2)) and hypoxia ( approximately 2% O(2)). Regardless of the oxygen concentration, 15d-PGJ(2) inhibited activity of hypoxia inducible factor-1 (HIF-1), the major hypoxic regulator of VEGF. However, in normoxic conditions 15d-PGJ(2) (1-10microM) activated the VEGF promoter and increased synthesis of the VEGF protein. Concomitantly, it strongly induced expression of HO-1. In contrast, in hypoxia, 15d-PGJ(2) decreased VEGF promoter activity and reduced VEGF release by 50%. Inhibition of HO-1 activity additionally attenuated VEGF synthesis in hypoxia. We conclude that induction of HO-1 by 15d-PGJ(2) results in augmentation of VEGF synthesis in normoxia. In hypoxia, however, the stimulatory effect of HO-1 is outweighed by 15d-PGJ(2)-mediated inhibition of the HIF-1 pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715242     DOI: 10.1016/j.bbrc.2003.12.059

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy.

Authors:  Anne R Diers; Brian P Dranka; Karina C Ricart; Joo Yeun Oh; Michelle S Johnson; Fen Zhou; Manuel A Pallero; Thomas M Bodenstine; Joanne E Murphy-Ullrich; Danny R Welch; Aimee Landar
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

Review 2.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

3.  Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes.

Authors:  Agnieszka Jazwa; Agnieszka Loboda; Slawomir Golda; Jaroslaw Cisowski; Magdalena Szelag; Anna Zagorska; Patrycja Sroczynska; Justyna Drukala; Alicja Jozkowicz; Jozef Dulak
Journal:  Free Radic Biol Med       Date:  2005-12-19       Impact factor: 7.376

Review 4.  New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genes.

Authors:  Jozef Dulak; Anna Zagorska; Barbara Wegiel; Agnieszka Loboda; Alicja Jozkowicz
Journal:  Cell Biochem Biophys       Date:  2006       Impact factor: 2.194

5.  Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappaB.

Authors:  Peter E M Gibbs; Tihomir Miralem; Mahin D Maines
Journal:  FASEB J       Date:  2010-04-21       Impact factor: 5.191

6.  Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.

Authors:  Cicerone Tudor; Nicole Lerner-Marmarosh; Yves Engelborghs; Peter E M Gibbs; Mahin D Maines
Journal:  Biochem J       Date:  2008-08-01       Impact factor: 3.857

Review 7.  Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.

Authors:  Jozef Dulak; Jessy Deshane; Alicja Jozkowicz; Anupam Agarwal
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

Review 8.  PPAR Gamma and Angiogenesis: Endothelial Cells Perspective.

Authors:  Jerzy Kotlinowski; Alicja Jozkowicz
Journal:  J Diabetes Res       Date:  2016-12-07       Impact factor: 4.011

9.  Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis.

Authors:  Barbara Wegiel; Anders Bjartell; Johanna Tuomela; Nishtman Dizeyi; Martina Tinzl; Leszek Helczynski; Elise Nilsson; Leo E Otterbein; Pirkko Härkönen; Jenny Liao Persson
Journal:  J Natl Cancer Inst       Date:  2008-07-08       Impact factor: 13.506

Review 10.  Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation.

Authors:  Bohae Rachel Lee; May Hnin Paing; Neelam Sharma-Walia
Journal:  Front Physiol       Date:  2021-07-15       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.